Looking at volume and this morning star would lead me to believe that we are in for some buying pressure to be introduced. I can definitely see 1720 coming in, especially with GSK's selling of parts of business to other firms: reuters.com/article/us-gsk-aspen-pharmacare-idUSKCN11I0LV